4//SEC Filing
CUBIST PHARMACEUTICALS INC 4
Accession 0001127602-13-020424
CIK 0000912183operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:46 PM ET
Size
12.7 KB
Accession
0001127602-13-020424
Insider Transaction Report
Form 4
Rosenberg Martin
Director
Transactions
- Award
Restricted Stock Units
2013-06-12+1,104→ 1,104 totalFrom: 2014-06-12→ Common Stock (1,104 underlying) - Award
Stock Options (Right to Buy)
2013-06-12+8,370→ 8,370 totalExercise: $50.24From: 2014-06-12Exp: 2023-06-12→ Common Stock (8,370 underlying)
Footnotes (5)
- [F1]The number of stock options represents the fair value of $129,500 calculated using the Black-Scholes option pricing model in accordance with ASC Topic 718, rounded down to the nearest whole share.
- [F2]Options vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2014 Annual Meeting of Stockholders.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
- [F4]The number of restricted stock units is equal to the fair value of $55,500 based on the stock price on the grant date, rounded down to the nearest whole share.
- [F5]The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date of the Company's 2014 Annual Meeting of Stockholders.
Documents
Issuer
CUBIST PHARMACEUTICALS INC
CIK 0000912183
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000912183
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:46 PM ET
- Size
- 12.7 KB